Arkolith/Insider Trading/LGND/Form 4

Sabba Stephen L

DirectorLIGAND PHARMACEUTICALS INC (LGND) · full profile →Form 4 · filed Jun 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$545K
Net Open-Market Flow
-$545K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2026Option exercise(M)2K$66.13$142K36K
Jun 16, 2026Sell(S)2K$254.00$545K34K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 16, 2026Option exercise(M)2K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-075456) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML